Consistent with the hypothesis, targeting hepatocyte DACH1 (HC-DACH1–KO mice) increased liver Plat mRNA, plasma tPA concentration and activity, and time to occlusive carotid thrombosis (Figure 2A). This evidence concerns the gene DACH1 and deep vein thrombosis.